scholarly journals The cardiovascular system in patients with diffuse toxic goiter

1995 ◽  
Vol 41 (5) ◽  
pp. 41-46
Author(s):  
F. F. Burumkulova ◽  
G. A. Kotova ◽  
G. A. Gerasimov

The lesion of the cardiovascular system is a frequent and serious complication of diffuse toxic goiter, which often comes to the fore in the clinical picture and determines the course and outcome of the disease. To refer to this lesion, R. Kraus introduced the term “thyrotoxic heart” in 1899, and now it refers to the symptom complex of disorders of the cardiovascular system caused by the toxic effects of excess thyroid hormones and characterized by the development of hyperfunction, hypertrophy, dystrophy, cardiosclerosis and heart failure.

2020 ◽  
Vol 24 (2) ◽  
Author(s):  
Katarzyna Lech-Badłak

Peadiatric inflammatory multisystem syndrome associated with COVID-19 is a new term that describes the COVID-19-associated multi-system inflammatory syndrome in children, which appeared in medical terminology with the spread of the SARS-CoV-2 pandemic. The connection with a past SARS-CoV-2 infection can usually be demonstrated by means of laboratory and molecular tests. The course of the disease is associated with dysfunction of the immune system, hence the clinical picture may be very similar to Kawasaki disease (initially this syndrome was called 'Kawasaki disease-like'). Cardiac complications, including heart failure, were also observed in PIMS. Therefore, cardiological diagnostics is necessary in every child diagnosed with PIMS. Moreover, it should be noted that a patient diagnosed with PIMS should be under the supervision of a multidisciplinary team of doctors. Both the treatment od PIMS and the clinical picture are similar to the treatment of Kawasaki disease. It is mainly based on the use of intravenous immunoglobulin, anticoagulants, and sometimes also glucocorticosteroids. After treatment, cardiological control is necessary due to possible complications in the cardiovascular system.


2006 ◽  
Vol 5 (1) ◽  
pp. 56-56
Author(s):  
A BARISON ◽  
L RONDININI ◽  
S GUIDERI ◽  
M COCEANI ◽  
M SCARLATTINI ◽  
...  

2010 ◽  
Vol 5 (1) ◽  
pp. 36-42
Author(s):  
Pasquale Conza ◽  
Flora Affuso ◽  
Serafino Fazio

1987 ◽  
Vol 9 (1) ◽  
pp. 57-61
Author(s):  
Toshiro Sato ◽  
Akihiro Takeuchi ◽  
Jun Yamagami ◽  
Hareaki Yamamoto ◽  
Shigeaki Akiyama ◽  
...  

Author(s):  
Tanuka Datta ◽  
Andrew J. Lee ◽  
Rachel Cain ◽  
Melissa McCarey ◽  
David J. Whellan

AbstractObesity is a growing worldwide epidemic with significant economic burden that carries with it impacts on every physiologic system including the cardiovascular system. Specifically, the risk of heart failure has been shown to increase dramatically in obese individuals. The purpose of this review is to provide background on the individual burdens of heart failure and obesity, followed by exploring proposed physiologic mechanisms that interconnect these conditions, and furthermore introduce treatment strategies for weight loss focusing on bariatric surgery. Review of the existing literature on patients with obesity and heart failure who have undergone bariatric surgery is presented, compared, and contrasted.


2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Mohammed A. Al-Heali ◽  
Zena A.M. Al-Jawadi

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Selim Bozkurt ◽  
Koray K. Safak

Dilated cardiomyopathy is the most common type of the heart failure which can be characterized by impaired ventricular contractility. Mechanical circulatory support devices were introduced into practice for the heart failure patients to bridge the time between the decision to transplant and the actual transplantation which is not sufficient due to the state of donor organ supply. In this study, the hemodynamic response of a cardiovascular system that includes a dilated cardiomyopathic heart under support of a newly developed continuous flow left ventricular assist device—Heart Turcica Axial—was evaluated employing computer simulations. For the evaluation, a numerical model which describes the pressure-flow rate relations of Heart Turcica Axial, a cardiovascular system model describing the healthy and pathological hemodynamics, and a baroreflex model regulating the heart rate were used. Heart Turcica Axial was operated between 8000 rpm and 11000 rpm speeds with 1000 rpm increments for assessing the pump performance and response of the cardiovascular system. The results also give an insight about the range of the possible operating speeds of Heart Turcica Axial in a clinical application. Based on the findings, operating speed of Heart Turcica Axial should be between 10000 rpm and 11000 rpm.


2021 ◽  
Vol 17 (3) ◽  
pp. 22-26
Author(s):  
I. A. Matsueva ◽  
A. B. Dalmatova ◽  
T. V. Andreychenko ◽  
E. N. Grineva

Treatment of thyrotoxicosis caused by Graves’ disease or multinodular toxic goiter, is not difficult, in most cases, since the prescription of thionamides allows to normalize the level of thyroid hormones quickly and safety. But in a number of cases this therapy might be associated with serious side effects (agranulocytosis, toxic hepatitis, cholestasis), severe allergic reactions and also individual intolerance on thionamides. In such cases lithium carbonate is used, especially in severe thyrotoxic syndrome. It is known, that lithium can accumulate in the thyroid gland at a concentration 3–4 times higher than in the plasma. Perhaps, lithium uses Na+/I- ions. It can inhibit the synthesis and secretion thyroid hormones of thyroid gland. The article presents the cases reported the use of lithium carbonate in thyrotoxicosis treatment before thyroidectomy. Administering low doses of carbonate lithium (900 mg/ per day) renders significant decrease or normalization of thyroid hormones concentration within 7–14 days, thus it let perform thyroidectomy on the patients. No side effects have been identified with such a short course of lithium carbonate treatment.


2021 ◽  
Vol 17 (5) ◽  
pp. 785-791
Author(s):  
A. A. Avagimyan ◽  
L. H. Mkrtchyan ◽  
A. A. Gevorkyan ◽  
N. B. Kononchuk ◽  
L. V. Kakturskiy ◽  
...  

The aim of this article is to represent the characterization of the clinical case of chemotherapy-related atrial fibrillation (AF) development in the young woman, elaborated as a result of multiple neoadjuvant and adjuvant modes of the intake of chemotherapy (both anthracycline based and non-anthracycline ones). In this case, the noted disturbances of heart rhythm should be recognized as a manifestation of cardiotoxicity. The latter implies the degree of detrimental effect of chemotherapeutical medication on the morphophynctional parameters of the cardiovascular system. Anthracycline drugs, being highly effective chemotherapytical agents, provide well-known toxic effects on the heart and vessels. Anthracycline mediated cardiotoxicity is a well- known veracity that dates back to the 60s of the last century, but up to now this medication sustains irreplaceable components of big volume of chemotherapy modes. Moreover, it should be noted that relatively newer drugs also posses certain cardiotoxicogenic potential.


Sign in / Sign up

Export Citation Format

Share Document